HLA-G DNA sequence variants and risk of perinatal HIV-I transmission

AIDS Research and Therapy

Volumn 3, Issue 1, 2006, Pages

  Aikhionbare, Felix O ^a   Kumaresan, K ^a   Shamsa, Falah ^a   Bond, Vincent C ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; HLA G ANTIGEN;

3' UNTRANSLATED REGION; AFRICAN AMERICAN; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DNA EXTRACTION; DNA SEQUENCE; EVIDENCE BASED MEDICINE; EXON; FEMALE; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HISPANIC; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFANT DISEASE; INFECTION RISK; MAJOR CLINICAL STUDY; MOTHER CHILD RELATION; PERINATAL PERIOD; PERIPHERAL BLOOD MONONUCLEAR CELL; PLACENTAL TRANSFER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; VIRUS TRANSMISSION;

EID: 33750945458     PISSN: 17426405     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-6405-3-28     Document Type: Article

References (30)

1. Kiarie JN, Richardson BA, Mbori-Ngacha D, Nduati RW, John-Stewart GC: Infant feeding practices of women in a perinatal HIV-I Prevention Study in Nairobi, Kenya. JAIDS 2004, 35(1):75-81.
2. Perez F, Orne-Gliemann J, Mukotekwa T, Miller A, Glenshaw M, Mahomva A, Dabis F: Prevention of mother to child transmission of HIV: evaluation of a pilot programme in a district hospital in rural Zimbabwe. BMJ 2004, 13; 329(7475):1147-1150.
3. Newell ML, Thorne C: Antiretroviral therapy and mother-to-child transmission of HIV-I. Expert Rev Anti Infec Ther 2006, 2(5):717-132.
4. Dekel B, Rubinstein M, Mazkeret R, Lotan D, Paret G: Common perinatal insults diminish cord blood RANTES. Biol Neonate 2002, 82(1):70-2.
5. Moss RB, Savary JR, Diveley JP, Jensen F, Carlo DJ: Maternal and newborn immunization with a human immunodeficiency virus-I immunogen in a rodent model. Immunology 2002, 106(4):549-53.
6. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, Demars R: A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990, 248(4952):220-223.
7. Hviid TV, Møller C, Sørensen S, Morling N: Co-dominant expression of the HLA-G gene and various forms of alternatively spliced HLA-G mRNA in human first trimester trophoblast. Hum Immunol 1998, 59(60):87-88.
8. Hviid TV, Sorensen S, Morling N: Polymorphisms in the regulatory region located more than 1.1 Kilobase 5′ to the start site of transcription, the promoter region and exon I of the HLA-G gene. Human Immunol 1999, 60(12):1237-1244.
9. Aikhionbare FO, Hodge T, Kuhn L, Bulterys M, Abrams EJ, Bond VC: Mother-to-child discordance in HLA-G exon 2 is associated with a reduced risk of perinatal HIV-I transmission. AIDS 2001, 15(16):2196-2198.
10. MacDonald KS, Embree J, Njenga S, Nagelkerke NJ, Ngatia I, Mohammed Z, Barber BH, Ndinya-Achola J, Bwayo J, Plummer FA: Mother-child class I HLA concordance increase perinatal human immunodeficiency virus type I transmission. J Infect Dis 1998, 177(3):551-556.
11. MacDonald KS, Embree JE, Nagelkerke NJ, Castillo J, Ramhadin S, Njenga S, Oyug J, Ndinya-Achola J, Barber BH, Bwayo JJ, Plummer FA: The HLA A2/ 6802 supertype is associated with reduced risk of perinatal human immunodeficiency virus type I transmission. J Infect Dis 2001, 163(3):503-506.
12. Arthur LO, Bess JW Jr, Sowder RC 2nd, Benveniste RE, Mann DL, Chermann J, Henderson LE: Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 1992, 238(5090):1935-1938.
13. Chan WL, Rodgers A, Hancock RD, Taffs F, Kitchin P, Farrar G, Liew FY: Protection in simian immunodeficiency virus-vaccinated monkeys correlates with ant-HLA Class I antibody response. J Exp Med 1992, 176(4):1203-1207.
14. Simonds RJ, Steketee R, Nesheim S, Matheson P, Palumbo P, Alger L, Abrams EJ, Orloff S, Lindsay M, Bardeguez AD, Vink P, Byers R, Rogers M: Impact of zidovudine use on risk and risk factors for perinatal HIV. Perinatal AIDS Collaborative Transmission Studies. AIDS 1998, 12(3):301-308.
15. van der Ven K, Ober C: HLA-G Polymorphisms in African Americans. J Immunol 1994, 153(12):5628-5633.
16. Geraghty DE, Koller BH, Orr HT: A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment. Proc Natl Acad Sci USA 1987, 84(24):9145-49.
17. Duan J, Wainwright MS, Comeron JM, Saitou N, Sanders AR, Gelernter J: Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mole Genet 2003, 12(3):205-216.
18. Matte C, Zijenah L, Lacaille J, Ward B, Roger M: Mother-to-child human leukocyte antigen G concordance: no impact on the risk of vertical transmission of HIV-I. AIDS 2002, 16(18):2491-2494.
19. Rousseau P, Le Discorde M, Mouillot G, Marcou C, Carosella ED, Moreau P: The 14 bp deletion-insertion polymorphism in the 3′ UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol 2003, 64(11):1005-1010.
20. Schust DJ, Hill AB, Ploegh HL: Herpes simplex virus blocks intracellular transport of HILA-G in placentally derived human cells. J Immunol 1996, 157(8):3375-3380.
21. Jun Y, Kim E, Jin M, Sung HC, Han H, Geraghty DE, Ahn K: Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules. J Immunol 2000, 164(2):805-811.
22. Ober C, Aldrich C, Chervoneva I, Billstrand C, Rahimov F, Gray HL, Hyslop T: Variation in the HLA-G promoter region influences miscarriage rates. AM J Hum Genet 2003, 72(6):1425-1435.
23. Matte C, Lacaille J, Zijenah L, Ward B, Roger M: ZVITAMBO Study Group. HLA-G exhibits low level of polymorphism in indigenous East Africans. Hum Immuol 2002, 63(6):495-501.
24. van der Ven K, Skrablin S, Ober C, Krebs D: HLA-G polymorphisms: ethnic differences and implications for potential molecular function. Am J Reprod Immunol 1998, 40(3):145-157.
25. Ishitani A, Kishida M, Sageshima N, Yashiki S, Sonoda S, Hayami M, Smith AG, Hatake K: Re-examination of HLA-G polymorphism in African Americans. Immunogenetics 1999, 49(9):808-811.
26. Gould SJ, Booth AM, Hildreth JE: The Trojan exosome hypothesis. PNAS 2003, 100(19):10592-10597.
27. Mofenson ML, McIntyre JA: Advances and research directions in the prevention of mother-to-child HIV-I transmission. Lancet 2000, 355(9222):2237-2244.
28. Bulterys M, Nolan ML, Jamieson DJ, Dominquez K, Fowler MG: Advances in the prevention of mother-to-child HIV-I transmission: Current issues, future challenges. AIDscience 2002, 2(4):1-19.
29. Cao Y, Krogsatd P, Korber BT, Koup RA, Muldoon M, Macken C, Song JL, Jin Z, Zhao JQ, Clapp S, Chen IS, Ho DD, Ammann AJ: Maternal HIV-Iviral load and vertical transmission of infection: Ariel Project for the prevention of HIV-I transmission from mother to infant. Nat Med 1997, 3(5):549-552.
30. Kourtis AP, Bulterys M, Nesheim SR, Lee FK: Understanding the timing of HIV transmission from mother to infant. JAMA 2001, 285(6):709-712.